Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition.
Seridi L, Cesaroni M, Orillion A, Schreiter J, Chevrier M, Marciniak S, Migone TS, Stohl W, Chatham WW, Furie RA, Benson J, Jordan J.
Seridi L, et al. Among authors: schreiter j.
Lupus. 2021 Apr;30(5):795-806. doi: 10.1177/0961203321995576. Epub 2021 Feb 24.
Lupus. 2021.
PMID: 33626969
Clinical Trial.